The Medicine Maker | Sitting Down With

Filter by

Outsourcing Cell & Gene Sitting Down With

Video: Sitting Down With… John Tomtishen

October 7, 2026

Catalent’s John Tomtishen discusses his path into cell therapy and the evolving approaches to CMC, manufacturing, and commercialization

1 min read

Outsourcing Regulation & Standards Business & Trends Sitting Down With

Quality Without Complexity: Interviewing Dipesh Patel

February 4, 2026

“Giving people enough space and a safe environment to do their job and innovate is fulfilling for them, and they will then, inevitably, develop solutions to the most pressing needs.”

4 min read

Quality Without Complexity: Interviewing Dipesh Patel

Outsourcing Business & Trends Sitting Down With

The Strategic Questions Reshaping the CDMO Map

January 22, 2026

We sit down with Joerg Ahlgrimm, CEO of SK pharmteco, to discuss his career and the changing landscape for outsourcing

9 min read

The Strategic Questions Reshaping the CDMO Map

Cell & Gene Bioprocessing Technology & Manufacturing Sitting Down With

Manufacturability and the Winners in Advanced Therapies

By Stephanie Vine

January 13, 2026

Are developers still underestimating the engineering sophistication required to scale advanced therapies in the real world? Alan Boyd discusses.

7 min read

Manufacturability and the Winners in Advanced Therapies

Interviews Sitting Down With Cell & Gene Development & Clinical

From the Apollo Era to the World's First Cell Therapy: Sitting Down With Bruce Levine

November 5, 2025

Bruce Levine shares his journey from a childhood steeped in science to co-founding the first CAR T-cell trials, and explains why communication and regulatory collaboration are crucial for the field’s future.

7 min read